High uric acid blood levels, known as hyperuricemia, are closely associated with stone formation via the regulatory role of URAT1 and OAT1 regulatory transporters of urate in humans, recognized as key therapeutic targets for hyperuricemia. Here, SLC22A12 is linked to hyperuricemia.